TRIB1
Basic information
Region (hg38): 8:125430358-125438403
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRIB1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 25 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 1 | 2 |
Variants in TRIB1
This is a list of pathogenic ClinVar variants found in the TRIB1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-125430916-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
8-125430922-G-A | not specified | Uncertain significance (Oct 13, 2023) | ||
8-125430960-G-T | not specified | Uncertain significance (May 17, 2023) | ||
8-125430966-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
8-125431026-G-T | not specified | Uncertain significance (Aug 02, 2021) | ||
8-125431086-C-A | not specified | Uncertain significance (Nov 09, 2022) | ||
8-125431086-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
8-125431108-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
8-125431131-G-C | not specified | Uncertain significance (Jun 27, 2023) | ||
8-125431147-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
8-125431155-G-A | not specified | Uncertain significance (Aug 19, 2023) | ||
8-125431213-A-G | not specified | Uncertain significance (Apr 18, 2023) | ||
8-125431237-A-G | not specified | Uncertain significance (Jan 03, 2022) | ||
8-125433476-C-T | not specified | Uncertain significance (Sep 07, 2022) | ||
8-125433477-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
8-125433488-C-T | not specified | Uncertain significance (May 30, 2023) | ||
8-125433506-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
8-125433595-C-T | Likely benign (Jul 26, 2018) | |||
8-125436033-A-C | not specified | Uncertain significance (Nov 18, 2023) | ||
8-125436172-C-T | not specified | Uncertain significance (May 11, 2022) | ||
8-125436188-T-C | not specified | Uncertain significance (Sep 29, 2023) | ||
8-125436255-C-T | Benign (Aug 28, 2018) | |||
8-125436286-A-G | not specified | Uncertain significance (Dec 18, 2023) | ||
8-125436341-C-T | not specified | Uncertain significance (Feb 14, 2023) | ||
8-125436343-G-A | not specified | Uncertain significance (Sep 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRIB1 | protein_coding | protein_coding | ENST00000311922 | 3 | 8085 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.833 | 0.166 | 125743 | 0 | 3 | 125746 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.21 | 119 | 162 | 0.733 | 0.0000100 | 2367 |
Missense in Polyphen | 19 | 40.421 | 0.47005 | 529 | ||
Synonymous | -1.05 | 81 | 69.8 | 1.16 | 0.00000459 | 796 |
Loss of Function | 2.68 | 1 | 10.3 | 0.0973 | 6.26e-7 | 136 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000616 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Adapter protein involved in protein degradation by interacting with COP1 ubiquitin ligase (PubMed:27041596). The COP1-binding motif is masked by autoinhibitory interactions with the protein kinase domain (PubMed:26455797). Serves to alter COP1 substrate specificity by directing the activity of COP1 toward CEBPA (PubMed:27041596). Binds selectively the recognition sequence of CEBPA (PubMed:26455797). Regulates myeloid cell differentiation by altering the expression of CEBPA in a COP1- dependent manner (By similarity). Controls macrophage, eosinophil and neutrophil differentiation via the COP1-binding domain (By similarity). Interacts with MAPK kinases and regulates activation of MAP kinases, but has no kinase activity (PubMed:15299019, PubMed:26455797). {ECO:0000250|UniProtKB:Q8K4K4, ECO:0000269|PubMed:15299019, ECO:0000269|PubMed:26455797, ECO:0000305|PubMed:27041596}.;
Recessive Scores
- pRec
- 0.166
Haploinsufficiency Scores
- pHI
- 0.629
- hipred
- N
- hipred_score
- 0.429
- ghis
- 0.489
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.993
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trib1
- Phenotype
- immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- protein phosphorylation;negative regulation of protein kinase activity;JNK cascade;negative regulation of smooth muscle cell migration;negative regulation of lipopolysaccharide-mediated signaling pathway;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;response to lipopolysaccharide;regulation of MAP kinase activity;negative regulation of DNA-binding transcription factor activity;positive regulation of eosinophil differentiation;positive regulation of macrophage differentiation;negative regulation of neutrophil differentiation;negative regulation of smooth muscle cell proliferation
- Cellular component
- nucleus;cytoplasm
- Molecular function
- protein kinase activity;protein kinase inhibitor activity;protein binding;ATP binding;transcription factor binding;mitogen-activated protein kinase kinase binding;ubiquitin protein ligase binding;ubiquitin-protein transferase regulator activity